Cargando…

Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line

BACKGROUND: Cisplatin is widely used for chemotherapy of head and neck squamous cell carcinoma. However, details of the molecular mechanism responsible for cisplatin resistance are still unclear. The aim of this study was to identify the expression of genes related to cisplatin resistance in oral sq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Ping, Zhang, Zhiyuan, Zhou, Xiaojian, Qiu, Weiliu, Chen, Fangan, Chen, Wantao
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1586025/ https://www.ncbi.nlm.nih.gov/pubmed/16978399 http://dx.doi.org/10.1186/1471-2407-6-224

Ejemplares similares

Tumor Suppressor LINC02487 Inhibits Oral Squamous Cell Carcinoma Cell Migration and Invasion Through the USP17–SNAI1 Axis
por: Feng, Lu, et al.
Publicado: (2020)

Response of lymphocyte subsets and cytokines to Shenyang prescription in Sprague-Dawley rats with tongue squamous cell carcinomas induced by 4NQO
por: Jiang, Canhua, et al.
Publicado: (2007)

Antisense oligonucleotides and all-trans retinoic acid have a synergistic anti-tumor effect on oral squamous cell carcinoma
por: Xu, Qin, et al.
Publicado: (2008)

The NF-kappa B inhibitor, celastrol, could enhance the anti-cancer effect of gambogic acid on oral squamous cell carcinoma
por: He, Di, et al.
Publicado: (2009)

Different cDNA microarray patterns of gene expression reflecting changes during metastatic progression in adenoid cystic carcinoma
por: Huang, Dan, et al.
Publicado: (2003)

Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis
por: Sun, Zujun, et al.
Publicado: (2012)

Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma
por: Shi, Jianbo, et al.
Publicado: (2019)

CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Feng, Zhien, et al.
Publicado: (2011)

EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines
por: Hiraishi, Yukihiro, et al.
Publicado: (2008)

Assessing Gene Expression Related to Cisplatin Resistance in Human Oral Squamous Cell Carcinoma Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2022)

The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
por: Feng, Xiaodong, et al.
Publicado: (2017)

Overexpression of β-Catenin Induces Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Li, Long, et al.
Publicado: (2016)

Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma
por: Luo, Sheng-Dean, et al.
Publicado: (2015)

Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2019)

Topoisomerase II trapping agent teniposide induces apoptosis and G2/M or S phase arrest of oral squamous cell carcinoma
por: Li, Jinzhong, et al.
Publicado: (2006)

Blocking circ-SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR-338-3p and regulating LIN28B
por: Qiu, Feng, et al.
Publicado: (2021)

Correction to: Blocking circ‑SCMH1 (hsa_circ_0011946) suppresses acquired DDP resistance of oral squamous cell carcinoma (OSCC) cells both in vitro and in vivo by sponging miR‑338‑3p and regulating LIN28B
por: Qiu, Feng, et al.
Publicado: (2022)

Analysis of the Differentially Expressed Genes Induced by Cisplatin Resistance in Oral Squamous Cell Carcinomas and Their Interaction
por: Wu, Hua-Tao, et al.
Publicado: (2020)

Increased FOXM1 Expression by Cisplatin Inhibits Paclitaxel-Related Apoptosis in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma (OSCC) Cell Lines
por: Choi, Hyeong Sim, et al.
Publicado: (2020)

The Differential Metabolic Response of Oral Squamous Cell Carcinoma Cells and Normal Oral Epithelial Cells to Cisplatin Exposure
por: Chen, Xun, et al.
Publicado: (2022)

The Molecular Basis and Therapeutic Aspects of Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Cheng, Yali, et al.
Publicado: (2021)

Compositional and Functional Analysis of the Microbiome in Tissue and Saliva of Oral Squamous Cell Carcinoma
por: Zhang, Zhen, et al.
Publicado: (2019)

Prognostic significance of p21, p27 and survivin protein expression in patients with oral squamous cell carcinoma
por: ZHANG, MINGBIN, et al.
Publicado: (2013)

Naa10p Enhances Chemosensitivity to Cisplatin in Oral Squamous Cell Carcinoma Cells
por: Sun, Lichun, et al.
Publicado: (2021)

The influence of p53 mutation status on the anti-cancer effect of cisplatin in oral squamous cell carcinoma cell lines
por: Jo, Deuk-Won, et al.
Publicado: (2016)

Evaluation of apoptotic effect of crocin, cisplatin, and their combination in human oral squamous cell carcinoma cell line HN5
por: Bijani, Fatima, et al.
Publicado: (2021)

M1-like tumor-associated macrophages activated by exosome-transferred THBS1 promote malignant migration in oral squamous cell carcinoma
por: Xiao, Meng, et al.
Publicado: (2018)

Cisplatin-Resistance in Oral Squamous Cell Carcinoma: Regulation by Tumor Cell-Derived Extracellular Vesicles
por: Khoo, Xin-Hui, et al.
Publicado: (2019)

Expression and oncogenic properties of membranous Notch1 in oral leukoplakia and oral squamous cell carcinoma
por: Ding, Xu, et al.
Publicado: (2018)

Synergistic cytotoxicity of cisplatin and Taxol in overcoming Taxol resistance through the inhibition of LDHA in oral squamous cell carcinoma
por: FENG, LIN, et al.
Publicado: (2015)

Cisplatin Plus Cetuximab Inhibits Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Migration and Proliferation but Does Not Enhance Apoptosis
por: Choi, Hyeong Sim, et al.
Publicado: (2021)

A pilot study of camrelizumab with docetaxel and cisplatin for the first line treatment in recurrent/metastatic oral squamous cell carcinoma
por: Ju, Houyu, et al.
Publicado: (2023)

Loss of Tumor Suppressor CYLD Expression Triggers Cisplatin Resistance in Oral Squamous Cell Carcinoma
por: Suenaga, Naoki, et al.
Publicado: (2019)

Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
por: Zhang, Mengxue, et al.
Publicado: (2021)

Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma
por: Sun, Wenwen, et al.
Publicado: (2021)

Direct Binding of Cisplatin to p22phox, an Endoplasmic Reticulum (ER) Membrane Protein, Contributes to Cisplatin Resistance in Oral Squamous Cell Carcinoma (OSCC) Cells
por: Hung, Chih-Chang, et al.
Publicado: (2020)

Gimeracil enhances the antitumor effect of cisplatin in oral squamous cell carcinoma cells in vitro and in vivo
por: Harada, Koji, et al.
Publicado: (2017)

Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma
por: Lv, Zhongjing, et al.
Publicado: (2014)

Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma
por: Li, Qiang, et al.
Publicado: (2020)

MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features
por: Ghosh, Ruma Dey, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_igijjl34rb8cv33n09d2brqk3c